ClinicalTrials.govpublic full text
Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
coronary artery disease, diabetes mellitus, type 2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 172531
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.